About: Clinical Characteristics and Differential Clinical Diagnosis of Novel Coronavirus Disease 2019 (COVID-19)

Facets (new session)
Description
Metadata
Settings
- owl:sameAs
- Inference Rule:

About: Clinical Characteristics and Differential Clinical Diagnosis of Novel Coronavirus Disease 2019 (COVID-19) Goto Sponge NotDistinct Permalink

An Entity of Type : schema:ScholarlyArticle, within Data Space : covidontheweb.inria.fr associated with source document(s)

Attributes	Values
type	Academic Article research paper schema:ScholarlyArticle
isDefinedBy	Covid-on-the-Web dataset
has title	Clinical Characteristics and Differential Clinical Diagnosis of Novel Coronavirus Disease 2019 (COVID-19)
Creator	Sharma, R Agarwal, M Saxena, Shailendra Saxena, S Sharma, Raman Agarwal, Madhulata Gupta, Mayank Gupta, · Somendra, Somyata Somendra, ·
topic	covid:2ad4a32315e1ce061a37ba49106dc886512b5883#this
Source	PMC
abstract	Novel Coronavirus Disease (COVID-19) has become a rapidly growing pandemic involving several nations. It is of serious concern and extreme challenge not only to the health personnel but also to the countries for containment. The causative organism is SARS-CoV-2, RNA virus of subgenus Sarbecovirus, similar to the SARS virus, and seventh member of the human coronavirus family responsible for this zoonotic infection. It binds to the human angiotensin converting enzyme (hACE-2) receptor and causes constitutional and respiratory symptoms. The major mode of transmission is human to human and the median incubation period is 4 days. The most common symptom as studied from various cohorts of COVID-19 patients are fever (83–98%) followed by fatigue (70%) and dry cough (59%); gastrointestinal symptoms are relatively uncommon differentiating it from SARS and MERS. Most of the SAR-CoV-2 infection are mild (80%) with a usual recovery period of 2 weeks. COVID-19 commonly affects males in the middle age and elderly age group, with highest case fatality (8–15%) among those aged >80 years. The disease begins with fever, dry cough, fatigue and myalgia progressing to dyspnoea and ARDS over 6 and 8 days post exposure, respectively. Underlying co-morbidities increase mortality in COVID-19. Poor prognostic factors are elderly, co-morbidities, severe lymphopaenia, high CRP and D-dimer >1 μg/L. The overall mortality rate ranges from 1.5 to 3.6%. COVID-19 has to be differentiated from other viral and bacterial pneumonias as they are more common among healthy adults. Despite constant and vigorous efforts by researchers and health agencies, we are far from containment, cure or prevention by vaccine; hence right information and stringent prevention and control measures are the only weapon in the armoury to combat the ongoing infection.
has issue date	2020-04-30(xsd:dateTime)
bibo:doi	10.1007/978-981-15-4814-7_6
has license	no-cc
sha1sum (hex)	2ad4a32315e1ce061a37ba49106dc886512b5883
schema:url	https://doi.org/10.1007/978-981-15-4814-7_6
resource representing a document's title	Clinical Characteristics and Differential Clinical Diagnosis of Novel Coronavirus Disease 2019 (COVID-19)
has PubMed Central identifier	PMC7189401
schema:publication	Coronavirus Disease 2019 (COVID-19)
resource representing a document's body	covid:2ad4a32315e1ce061a37ba49106dc886512b5883#body_text
is http://vocab.deri.ie/void#inDataset of	proxy:http/ns.inria.fr/covid19/2ad4a32315e1ce061a37ba49106dc886512b5883
is schema:about of	named entity 'CRP' named entity 'Sarbecovirus' named entity 'major mode' named entity 'middle age' named entity 'control' named entity '8 days' named entity 'extreme' named entity 'prevention' named entity 'agencies' named entity 'involving' named entity 'MILD' named entity 'SUBGENUS' named entity 'HIGH' named entity 'HEALTHY' named entity 'COVID-19' covid:arg/2ad4a32315e1ce061a37ba49106dc886512b5883 named entity 'fever' named entity 'SARS-CoV-2' named entity 'symptoms' named entity 'converting' named entity 'vaccine' named entity 'common' named entity 'mortality' named entity 'viral' named entity 'COVID-19' named entity 'group' named entity 'infection' named entity 'patients' named entity 'infection' named entity 'stringent' named entity 'Most' named entity 'weapon' named entity 'COVID-19' named entity 'Poor' named entity 'prognostic' named entity '2019' named entity 'Novel' named entity 'SARS-CoV-2' named entity 'angiotensin converting enzyme' named entity 'gastrointestinal symptoms' named entity 'zoonotic infection' named entity 'mode of transmission' named entity 'Sarbecovirus' named entity 'dry cough' named entity '8 days' named entity 'organism' named entity 'virus' named entity 'incubation period' named entity 'fatigue' named entity 'mortality rate' named entity 'Coronavirus Disease 2019' named entity 'COVID' named entity 'Clinical Characteristics' named entity 'microbiologists' named entity 'epidemiologists' named entity 'case fatality' named entity 'symptom' named entity 'Iran' named entity 'epidemiological' named entity 'COVID' named entity 'COVID-19' named entity 'receptor' named entity 'pneumonia' named entity 'COVID-19' named entity 'cytokine storm' named entity 'magic bullet' named entity 'shortness of breath' named entity 'RSV' named entity 'virus' named entity 'vaccine' named entity 'Asian' named entity 'global pandemic'

Faceted Search & Find service v1.13.91 as of Mar 24 2020

Alternative Linked Data Documents: Sponger | ODE Content Formats:

RDF

ODATA

Microdata

About

OpenLink Virtuoso version 07.20.3229 as of Jul 10 2020, on Linux (x86_64-pc-linux-gnu), Single-Server Edition (94 GB total memory)
Data on this page belongs to its respective rights holders.
Virtuoso Faceted Browser Copyright © 2009-2024 OpenLink Software